Liu Q, Liu H, Li L, Dong X, et al. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation. Int J Oncol 2019 Nov 14. doi: 10.3892/ijo.2019.4913.
PMID: 31746426